Notice Announcing FAQs Page for PAR-18-307 "Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)" and PAR-18-324 "Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)"

Notice Number: NOT-OD-18-208

Key Dates
Release Date: July 10, 2018

Related Announcements
PAR-18-307
PAR-18-324

Issued by
Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)

Purpose

On October 10, 2017, and October 17, 2017, the Office of Disease Prevention re-issued two Funding Opportunity Announcements (FOAs) PAR-18-307 "Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)” and PAR-18-324 "Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)." To assist prospective applicants with the above-referenced FOAs, this Notice provides an FAQ page for prospective applicants.

FAQs Page
As a result of discussions with various applicants regarding permissible research plans under these FOAs, NIH developed a list of Frequently Asked Questions (FAQs) to address these inquiries. The FAQs for these FOAs is posted at:  https://prevention.nih.gov/docs/resources-researchers/funding/PAR_18_324_PAR_18_307_FAQs.pdf. The FAQs may be updated without additional notice. In addition to the FAQs, NIH staff will also respond to questions submitted by potential applicants to the Agency Contacts listed in the FOAs.

Inquiries

Please direct all inquiries to:

Stephanie M. George, Ph.D., M.P.H., M.A.
Office of Disease Prevention (ODP)
Telephone: 301-827-5562
Email: stephanie.george@nih.gov